219
Participants
Start Date
July 1, 2009
Primary Completion Date
March 4, 2015
Study Completion Date
March 4, 2015
Ruxolitinib
5 mg tablets packaged as 60-count in high-density polyethylene bottles
Best Available Therapy (BAT)
Prescribing and usage per respective package inserts
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Brussels
Novartis Investigative Site, Antwerp
Novartis Investigative Site, Antwerp
Novartis Investigative Site, Leuven
Novartis Investigative Site, Hasselt
Novartis Investigative Site, Linz
Novartis Investigative Site, Salzburg
Novartis Investigative Site, Yvoir
Novartis Investigative Site, Maastricht
Novartis Investigative Site, Innsbruck
Novartis Investigative Site, La Louvière
Novartis Investigative Site, Bruges
Novartis Investigative Site, Kortrijk
Novartis Investigative Site, Roeselare
Novartis Investigative Site, Orbassano
Novartis Investigative Site, Marseille
Novartis Investigative Site, Berlin
Novartis Investigative Site, Caen
Novartis Investigative Site, Milan
Novartis Investigative Site, Monza
Novartis Investigative Site, Pavia
Novartis Investigative Site, Pavia
Novartis Investigative Site, Majadahonda
Novartis Investigative Site, Nîmes
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Pessac
Novartis Investigative Site, Grenoble
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Valencia
Novartis Investigative Site, Münster
Novartis Investigative Site, Florence
Novartis Investigative Site, Cologne
Novartis Investigative Site, Mainz
Novartis Investigative Site, Lille
Novartis Investigative Site, Frankfurt/M
Novartis Investigative Site, Lens
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Lyon
Novartis Investigative Site, Stuttgart
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
Novartis Investigative Site, Amiens
Novartis Investigative Site, Poitiers
Novartis Investigative Site, Ulm
Novartis Investigative Site, Villejuif
Novartis Investigative Site, Vienna
Novartis Investigative Site, Rennes
Novartis Investigative Site, Groningen
Novartis Investigative Site, Nijmegen
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, The Hague
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Gothenburg
Novartis Investigative Site, Stockholm
Novartis Investigative Site, Belfast
Novartis Investigative Site, Cambridge
Novartis Investigative Site, London
Novartis Investigative Site, Oxford
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY